Phesgo 60 mg (Trastuzumab SOLUTION) 60 MG

PHESGO 60 MG is a subcutaneous solution containing trastuzumab, used for targeted therapy in certain cancer treatments. This medication is designed for subcutaneous administration and is manufactured by Hoffmann-La Roche Limited in Canada.

Strength

60 MG

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PHESGO 60 MG is primarily used in the treatment of specific types of cancer, particularly those that involve the HER2 protein. It is often prescribed as part of a targeted therapy regimen to help manage and treat certain cancers. The medication works by targeting and blocking the action of the HER2 protein, which can be overproduced in some cancer cells, leading to their growth and division.

Side Effects

Common effects of PHESGO 60 MG may include reactions at the injection site, such as redness, swelling, or pain. Some individuals may also experience fatigue, nausea, or fever. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

PHESGO 60 MG should be handled with care and administered as directed by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting this medication. Store the solution at the recommended temperature and keep it out of reach of children.

Avoid Interactions

PHESGO 60 MG may interact with other medications, including those that affect the immune system or other cancer treatments. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it is best to follow your healthcare provider's advice regarding diet and lifestyle.

Frequently Asked Questions

PHESGO 60 MG is used in the treatment of certain types of cancer, particularly those involving the HER2 protein.

PHESGO 60 MG is administered subcutaneously, typically by a healthcare professional.

Common effects may include reactions at the injection site, fatigue, nausea, or fever.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

PHESGO 60 MG should be stored at the recommended temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.